| Localized melanoma in older patients, the impact of increasing age and comorbid medical conditions MJ Rees, H Liao, J Spillane, D Speakman, C McCormack, S Donahoe, ... European Journal of Surgical Oncology (EJSO) 42 (9), 1359-1366, 2016 | 28 | 2016 |
| Melanoma in the very elderly, management in patients 85 years of age and over MJ Rees, H Liao, J Spillane, D Speakman, C McCormack, S Donahoe, ... Journal of geriatric oncology 9 (5), 488-493, 2018 | 23 | 2018 |
| High‐risk multiple myeloma: Redefining genetic, clinical, and functional high‐risk disease in the era of molecular medicine and immunotherapy MJ Rees, S Kumar American Journal of Hematology, 2024 | 7 | 2024 |
| BCMA-directed therapy, new treatments in the myeloma toolbox, and how to use them MJ Rees, S Kumar Leukemia & Lymphoma 65 (3), 287-300, 2024 | 7 | 2024 |
| Navigating High-Risk and Ultrahigh-Risk Multiple Myeloma: Challenges and Emerging Strategies MJ Rees, M D'Agostino, LB Leypoldt, S Kumar, KC Weisel, F Gay American Society of Clinical Oncology Educational Book 44 (3), e433520, 2024 | 7 | 2024 |
| The association of mobilising regimen on immune reconstitution and survival in myeloma patients treated with bortezomib, cyclophosphamide and dexamethasone induction followed … MJ Rees, P Mollee, JY Ng, A Murton, JF Gonsalves, A Panigrahi, H Beer, ... Bone marrow transplantation 56 (9), 2152-2159, 2021 | 6 | 2021 |
| Massive oxidative haemolysis and renal failure caused by high dose vitamin C MJ Rees, MC Strach, K Burbury, KA Phillips The Medical Journal of Australia 209 (6), 248-249, 2018 | 6 | 2018 |
| Paraneoplastic systemic lupus erythematosus associated with colorectal cancer MJ Rees, A Steinberg, E Romas, S Ford, V Roberts, FL Ierino Oxford Medical Case Reports 2019 (2), omy131, 2019 | 5 | 2019 |
| Targeting the BRAF pathway in haematological diseases MJ Rees, M Dickinson, J Paterson, TF Ng, A Grigg, J Moore, P Blombery, ... Internal Medicine Journal 53 (5), 845-849, 2023 | 4 | 2023 |
| The real-world tolerability and efficacy of asparaginase in adults aged 40 years and older with Philadelphia-negative acute lymphoblastic leukemia MJ Rees, S Wu, M Mokoonlall, CHK Dix, CE Bryant, J D’Rozario, ... Leukemia & lymphoma 62 (10), 2531-2534, 2021 | 3 | 2021 |
| Purulent pneumococcal pericarditis, a vaccine-preventable illness MJ Rees, A Wilson Oxford medical case reports 2019 (8), omz078, 2019 | 3 | 2019 |
| Clinical features associated with poor response and early relapse following BCMA-directed therapies in multiple myeloma MJ Rees, A Mammadzadeh, A Bolarinwa, ME Elhaj, A Bohra, R Bansal, ... Blood cancer journal 14 (1), 122, 2024 | 2 | 2024 |
| Real world outcome of patients with multiple myeloma who received bispecific antibodies after CAR-T therapy. R Bansal, A De Menezes Silva Corraes, L Brunaldi, TB Sandahl, MJ Rees, ... Journal of Clinical Oncology 42 (16_suppl), 7520-7520, 2024 | 2 | 2024 |
| The impact of G-CSF alone vs G-CSF and cyclophosphamide mobilisation on autograft immune cell content in multiple myeloma MJ Rees, A Panigrahi, SJ Harrison, A Spencer, T Khong, S Gibbs, ... Bone marrow transplantation 57 (6), 1001-1003, 2022 | 2 | 2022 |
| Characteristics and outcomes of incidentally diagnosed diffuse large B-cell lymphoma and implications for cancer screening SA Atallah-Yunes, MJ Rees, R Mwangi, RL Kuchler, GS Nowakowski, ... American journal of hematology 100 (1), 158-162, 2025 | 1 | 2025 |
| CODOX-M/IVAC-R versus DA-EPOCH-R in double/triple-hit large B cell lymphoma in patients≤ 60 years. SA Atallah-Yunes, MJ Rees, TE Witzig, TM Habermann, ED McPhail, ... Journal of Clinical Oncology 42 (16_suppl), 7067-7067, 2024 | 1 | 2024 |
| Class comparison of BCMA-directed therapies in relapsed multiple myeloma. MJ Rees, A Mammadzadeh, A Bolarinwa, ME Elhaj, A Bohra, S Ailawadhi, ... Journal of Clinical Oncology 42 (16_suppl), 7515-7515, 2024 | 1 | 2024 |
| High rate of durable remissions post autologous stem cell transplantation for core-binding factor acute myeloid leukaemia in second complete remission MJ Rees, A Spencer, P Browett, F Alvaro, D Purtill, J Crawford, S Milliken, ... Bone marrow transplantation 55 (11), 2207-2210, 2020 | 1 | 2020 |
| Proteomic Determinants of Renal Organ Response in AL Amyloidosis MJ Rees, E Muchtar, SA Atallah-Yunes, S Dasari, N Leung, MA Gertz, ... Blood 144, 3305, 2024 | | 2024 |
| Improved Survival with Daratumumab-Cybord Compared to Cybord As Frontline Therapy in Immunoglobulin Light Chain (AL) Amyloidosis B Yohannan, MJ Rees, MA Gertz, A Dispenzieri, F Buadi, D Dingli, ... Blood 144, 2400, 2024 | | 2024 |